[Medical treatment of hyperprolactinemic states using lisuride, a prolonged-action dopaminergic].
Zárate
A
A
Fonseca
M E
ME
Moran
C
C
Miranda
R
R
D000328:Adult; D000858:Anovulation / Q000188:drug therapy; D003692:Delayed-Action Preparations; D015259:Dopamine Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D008090:Lisuride / Q000008:administration & dosage / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000188:drug therapy; D015175:Prolactinoma / Q000188:drug therapy
D003692:Delayed-Action Preparations; D015259:Dopamine Agents; D004873:Ergolines; D008090:Lisuride
Tratamiento médico de los estados hiperprolactinémicos con lisurida, un dopaminérgico de acción prolongada.